Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation

British Journal of Pharmacology

Volumn 148, Issue 2, 2006, Pages 200-207

  Sato, Koichi ^a   Ninomiya, Hiromichi ^a   Ohkura, Shinsuke ^a   Ozaki, Hiroshi ^b   Nasu, Tetsuyuki ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colonic smooth muscle; Inflammatory bowel disease; Motility disorder; Protease activated receptor 2

Indexed keywords

1 ETHYLBENZIMIDAZOLIN 2 ONE; APAMIN; BENZIMIDAZOLE DERIVATIVE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARBACHOL; DEXTRAN SULFATE; HEXAMETHONIUM; MESSENGER RNA; N(G) METHYLARGININE; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; PROPRANOLOL; PROTEINASE ACTIVATED RECEPTOR 2; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; TETRODOTOXIN; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; ENTERITIS; INFLAMMATION; INTESTINE MOTILITY; INTESTINE MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

ANIMALS; APAMIN; CARBACHOL; COLITIS; COLON; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; OLIGOPEPTIDES; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; TRYPSIN;

EID: 33745012669     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706717     Document Type: Article

References (38)

1. AKBARALI, H.I., POTHOULAKIS, C. & CASTAGLIUOLO, I. (2000). Altered ion channel activity in murine colonic smooth muscle myocytes in an experimental colitis model. Biochem. Biophys. Res. Commun., 275, 637-642.
2. AL-SAFFAR, A. & HELLSTROM, P.M. (2001). Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand. J. Gastroenterol., 36, 485-493.
3. ANNESE, V., BASSOTTI, G., NAPOLITANO, G., USAI, P., ANDRIULLI, A. & VANTRAPPEN, G. (1997). Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand. J. Gastroenterol., 32, 1107-1117.
4. BOHM, S.K., KHITIN, L.M., GRADY, E.F., APONTE, G., PAYAN, D.G. & BUNNETT, N.W. (1996). Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J. Biol. Chem., 271, 22003-22016.
5. BOSSONE, C., HOSSEINI, J.M., PINEIRO-CARRERO, V. & SHEADONOHUE, T. (2001). Alterations in spontaneous contractions in vitro after repeated inflammation of rat distal colon. Am. J. Physiol. Gastrointest. Liver Physiol., 280, G949-G957.
6. BRADFORD, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. BRADLEY, P.P., PRIEBAT, D.A., CHRISTENSEN, R.D. & ROTHSTEIN, G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol., 78, 206-209.
8. CAMERER, E., HUANG, W. & COUGHLIN, S.R. (2000). Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. U.S.A., 97, 5255-5260.
9. CENAC, N., COELHO, A.M., NGUYEN, C., COMPTON, S., ANDRADE-GORDON, P., MACNAUGHTON, W.K., WALLACE, J.L., HOLLENBERG, M.D., BUNNETT, N.W., GARCIA-VILLAR, R., BUENO, L. & VERGNOLLE, N. (2002). Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol., 161, 1903-1915.
10. CENAC, N., GARCIA-VILLAR, R., FERRIER, L., LARAUCHE, M., VERGNOLLE, N., BUNNETT, N.W., COELHO, A.M., FIORAMONTI, J. & BUENO, L. (2003). Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J. Immunol., 170, 4296-4300.
11. CORVERA, C.U., DERY, O., MCCONALOGUE, K., GAMP, P., THOMA, M., AL-ANI, B., CAUGHEY, G.H., HOLLENBERG, M.D. & BUNNETT, N.W. (1999). Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J. Physiol., 517, 741-756.
12. DEPOORTERE, I., THIJS, T. & PEETERS, T.L. (2002). Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis. Br. J. Pharmacol., 135, 2011-2019.
13. HOLLENBERG, M.D., SAIFEDDINE, M. & AL-ANI, B. (1996). Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol. Pharmacol., 49, 229-233.
14. ISHIHARA, H., CONNOLLY, A.J., ZENG, D., KAHN, M.L., ZHENG, Y.W., TIMMONS, C., TRAM, T. & COUGHLIN, S.R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
15. KAWABATA, A. (2002). PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev. Mol. Med., 2002, 1-17.
16. KAWABATA, A., KURODA, R., KUROKI, N., NISHIKAWA, H. & KAWAI, K. (2000a). Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. Br. J. Pharmacol., 131, 578-584.
17. KAWABATA, A., KURODA, R., KUROKI, N., NISHIKAWA, H., KAWAI, K. & ARAKI, H. (2000b). Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle. Life Sci., 67, 2521-2530.
18. KAWABATA, A., NISHIKAWA, H., KURODA, R., KAWAI, K. & HOLLENBERG, M.D. (2000c). Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br. J. Pharmacol., 129, 1808-1814.
19. 2+ channels and its reversal by NF-κB inhibitors in Crohn's colitis model. Am. J. Physiol. Gastrointest. Liver Physiol., 285, G483-G493.
20. KOCH, T.R., CARNEY, J.A., GO, V.L. & SZURSZEWSKI, J.H. (1988). Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis. Gastroenterology, 95, 77-84.
21. LINDEN, D.R., MANNING, B.P., BUNNETT, N.W. & MAWE, G.M. (2001). Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons. Eur. J. Pharmacol., 431, 311-314.
22. MATSUMOTO, T., YOSHIYAMA, S., WAKABAYASHI, K., KOBAYASHI, T. & KAMATA, K. (2004). Effect of chronic insulin on cromakalim-induced relaxation in established streptozotocin-diabetic rat basilar artery. Eur. J. Pharmacol., 504, 129-137.
23. MIZUTA, Y., ISOMOTO, H. & TAKAHASHI, T. (2000). Impaired nitrergic innervation in rat colitis induced by dextran sulfate sodium. Gastroenterology, 118, 714-723.
24. MULE, F., BAFFI, M.C., CAPPARELLI, A. & PIZZUTI, R. (2003). Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle. Br. J. Pharmacol., 139, 598-604.
25. MULE, F., BAFFI, M.C. & CERRA, M.C. (2002a). Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br. J. Pharmacol., 136, 367-374.
26. MULE, F., BAFFI, M.C., FALZONE, M. & CERRA, M.C. (2002b). Signal transduction pathways involved in the mechanical responses to protease-activated receptors in rat colon. J. Pharmacol. Exp. Ther., 303, 1265-1272.
27. NGUYEN, T.D., MOODY, M.W., STEINHOFF, M., OKOLO, C., KOH, D.S. & BUNNETT, N.W. (1999). Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J. Clin. Invest., 103, 261-269.
28. NISHIKAWA, H., KAWAI, K., NISHIMURA, S., TANAKA, S., ARAKI, H., AL-ANI, B., HOLLENBERG, M.D., KURODA, R. & KAWABATA, A. (2002). Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats. Eur. J. Pharmacol., 447, 87-90.
29. NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 9208-9212.
30. NYSTEDT, S., RAMAKRISHNAN, V. & SUNDELIN, J. (1996). The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem., 271, 14910-14915.
31. OHAMA, T., HORI, M., SATO, K., OZAKI, H. & KARAKI, H. (2003). Chronic treatment with interleukin-1β attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J. Biol. Chem., 278, 48794-48804.
32. OSSOVSKAYA, V.S. & BUNNETT, N.W. (2004). Protease-activated receptors: contribution to physiology and disease. Physiol. Rev., 84, 579-621.
33. REDDY, S.N., BAZZOCCHI, G., CHAN, S., AKASHI, K., VILLANUEVA-MEYER, J., YANNI, G., MENA, I. & SNAPE Jr, W.J. (1991). Colonic motility and transit in health and ulcerative colitis. Gastroenterology, 101, 1289-1297.
34. 2+ mobilization in circular muscle cells of the inflamed colon. Am. J. Physiol. Gastrointest. Liver Physiol., 278, G234-G242.
35. VAN BERGEIJK, J.D., VAN WESTREENEN, H., ADHIEN, P. & ZIJLSTRA, F.J. (1998). Diminished nitroprusside-induced relaxation of inflamed colonic smooth muscle in mice. Mediators Inflamm., 7, 283-287.
36. VERGNOLLE, N. (2000). Review article: Proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol. Ther., 14, 257-266.
37. VU, T.K., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
38. WEINSTEIN, J.R., LAU, A.L., BRASS, L.F. & CUNNINGHAM, D.D. (1998). Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line. J. Neurochem., 71, 1034-1050.